2-es típusú cukorbetegség: vizsgálatok itt: Tajvan
29 of 37 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Chia-Yi City, Kaohsiung City, New Taipei City, Taichung, Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisNot yet taking people in TajvanA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both
- Where
- Chiayi City, Taichung, Tainan, Taoyuan City
- Életkor
- 18 év and over
- People
- 1060 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931599 · EU 2026-525474-20-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Changhua, Chiayi City, Kaohsiung City, Taichung, Tainan, Taipei
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Changhua, Chiayi City, Kaohsiung City, Taichung, Tainan, Taipei
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisNot yet taking people in TajvanA Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Where
- Taichung, Taoyuan
- Életkor
- 10 év to 17 év
- People
- 170 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Kaohsiung City, Kaohsiung Niao Sung Dist, Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Chiayi City, Kaohsiung City, Kaohsiung Niao Sung Dist, Taichung, Tainan, Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 3. fázisNot yet taking people in TajvanA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Hsinchu
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Tainan County, Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Changhua, Chiayi City, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Changhua, Kaohsiung City, Taichung, Tainan, Taipei, Zhubei
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 3. fázisTaking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan, Yung Kang City
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - 3. fázisNot yet taking people in TajvanA Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Where
- Taipei
- Életkor
- 10 év to 18 év
- People
- 80 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07282613 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Changhua, Kaohsiung City, Taichung, Tainan, Tainan County, Taipei
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Chiayi City, Kaohsiung City, Kaohsiung Niao Sung Dist, Taipei
- Életkor
- 18 év and over
- People
- 1980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan, Zhubei
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Where
- Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Tainan County, Taipei
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00 - No phaseNot yet taking people in TajvanHCC Risk and Monitoring in Patients With Type 2 Diabetes
- Where
- Taipei
- Életkor
- 18 év and over
- People
- 2400
- Run by
- National Taiwan University Hospital
See details and how to joinNCT07675187 - No phaseNot yet taking people in TajvanAI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patients Managed by Non-Specialist Physicians
- Where
- Taipei
- Életkor
- 19 év to 80 év
- People
- 400
- Run by
- National Taiwan University Hospital
See details and how to joinNCT07684690 - No phaseCsak meghívásosDigital Health Solutions for Patients With Type 2 Diabetes
- Where
- Taoyuan
- Életkor
- 20 év to 75 év
- People
- 60
- Run by
- Chang Gung Memorial Hospital
See details and how to joinNCT07642830 - No phaseTaking peopleMultimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia
- Where
- Taichung
- Életkor
- 45 év to 85 év
- People
- 128
- Run by
- yueh chu wu
See details and how to joinNCT07398495 - No phaseNot yet taking people in TajvanEssential Oil-Assisted Respiratory Training in Type 2 Diabetic Patients With Lung Infections
- Where
- Taipei
- Életkor
- 18 év to 90 év
- People
- 100
- Run by
- National Taipei University of Nursing and Health Sciences
See details and how to joinNCT07103460 - No phaseTaking peopleInnovative Approaches in Diabetes Care
- Where
- Taipei
- Életkor
- 20 év and over
- People
- 39
- Run by
- Taipei Medical University
See details and how to joinNCT05687968 - 4. fázisNot yet taking people in TajvanThe Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms
- Where
- Taipei
- Életkor
- 20 év and over
- People
- 60
- Run by
- Taipei Veterans General Hospital, Taiwan
See details and how to joinNCT07073053 - No phaseTaking peopleEffects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes
- Where
- Hsinchu
- Életkor
- 18 év and over
- People
- 130
- Run by
- National Taiwan University Hospital
See details and how to joinNCT06331338